Clinical Trial Evaluating the Efficacy of Capecitabine Plus Lenvatinib in Patients With Advanced Colorectal Cancer Refractory to Irinotecan, Oxaliplatin, and Fluoropyrimidine
Clinical trial NCT07683949 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07683949
- Sponsor
- Seoul National University Bundang Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-15
- Primary completion
- 2029-10-31
- Enrollment
- 93
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.